Fin and min progress 1 year in 9/24/2026
Similar Community Posts Join
6 / 6 resultscommunity Progress pictures 4 years initially fin + min then 1 year dermarolling.
User shared progress pictures after 4 years of using Minoxidil and Finasteride, and 1 year of dermarolling. They seek advice on additional treatments to improve hair loss results.
community Fin and min progress 1 year in!
The user has been using oral finasteride and minoxidil for hair loss since late 2025, with an increased minoxidil dose in May 2026, and is considering switching to dutasteride. They report no significant side effects except slightly watery semen and have not experienced hair shedding.
community 24M oral fin/min 1 year progress
A 24-year-old male shares his one-year progress using oral finasteride (1 mg) and minoxidil (3 mg) for hair growth, reporting positive results without significant side effects. Other users discuss their experiences with these treatments, including concerns about side effects and the importance of consulting a doctor.
community 5 year Fin + topical Min progress, switch to Duta+Oral Min January 1st 2026.
The user shared their 5-year progress using finasteride and topical minoxidil for hair growth, noting initial success but recent thinning and side effects. They plan to switch to dutasteride and oral minoxidil, addressing low iron levels and monitoring potential side effects.
community 1 year on fin + min progress pictures
The user shared progress pictures after one year of using finasteride and minoxidil for hair loss. They initially tried microneedling but stopped due to pain and side effects.
community 3-year fin/min plateau broken? Crown progress update (May 2025 – Present)
The user experienced significant hair regrowth after adding GHK-Cu injections to their existing treatment of topical finasteride and oral minoxidil, breaking a long plateau. They are curious if others have had similar experiences with adding new treatments to their regimen.
Related Research
6 / 6 resultsresearch 5-Alpha-Reductase Inhibitors and Combination Therapy
This study found that combining 5-alpha reductase inhibitors with alpha-blockers provided the best symptomatic relief and reduced the risk of clinical progression for BPH, while PDE5 inhibitors could offset sexual side effects.
research Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
This study suggests that inhibitors of steroidogenic enzymes may have therapeutic potential for certain behavioral disorders linked to dopaminergic hyperfunction, despite concerns about their endocrine impacts.
research Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
This study found that dual inhibition of BACE1 and BACE2 in mice affects melanosome maturation and causes dose-dependent hair depigmentation without altering retinal morphology.
research Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
In this study, researchers observed that individuals with alopecia areata exhibited significant changes in scalp microbiota diversity and composition, which were linked to disease severity and inflammation markers, though it remains unclear if these microbial shifts are a cause or a result of hair loss.
research Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
This review discusses the various evidence-based and potential applications of metformin in treating and preventing symptoms and complications associated with polycystic ovary syndrome but reports no new clinical results.
research Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
This study found that young women with PCOS exhibited altered white matter microstructure and reduced cognitive performance compared to matched controls.